| Dana-Farber Cancer Institute |
Level I |
11 | 81 |
$45,000 |
| Eurofins Professional Scientific Services New England, LLC. |
Level II |
8 | 8 |
$61,360 |
| Brigham and Women's Hospital |
Level I |
4 | 4 |
$52,500 |
| General Hospital Corporation |
Level II |
4 | 4 |
$52,728 |
| Aera Therapeutics, Inc. |
Level III |
3 | 3 |
$90,000 |
| Biocytogen Boston Corp. |
Level III |
3 | 3 |
$72,000 |
| Children's Hospital Corporation |
Level II |
3 | 3 |
$60,008 |
| Eurofins Professional Scientific Services New England, LLC. |
Level III |
3 | 3 |
$75,000 |
| ModernaTX, Inc. |
Level IV |
3 | 3 |
$89,900 |
| Whitehead Institute for Biomedical Research |
Level I |
3 | 3 |
$47,500 |
| Yoh, A Day & Zimmermann Company |
Level IV |
3 | 3 |
$84,240 |
| Akston Biosciences Corporation |
Level III |
2 | 2 |
$70,000 |
| Brigham and Women's Hospital |
Level II |
2 | 2 |
$53,000 |
| Children's Hospital Corporation |
Level III |
2 | 2 |
$67,484 |
| Dana-Farber Cancer Institute |
Level II |
2 | 2 |
$54,000 |
| Entrada Therapeutics, Inc. |
Level IV |
2 | 2 |
$89,557 |
| Etiome, Inc. |
Level III |
2 | 2 |
$85,000 |
| InnDura Therapeutics Inc. |
Level I |
2 | 2 |
$70,000 |
| Sanofi Vaccines US Inc. |
Level IV |
2 | 2 |
$77,501 |
| Tufts University |
Level I |
2 | 2 |
$48,079 |
| Tufts University |
Level II |
2 | 2 |
$67,751 |
| Aequor Technologies, Inc. |
Level III |
1 | 1 |
$69,680 |
| Aera Therapeutics, Inc. |
Level II |
1 | 1 |
$70,000 |
| Affinia Therapeutics Inc. |
Level IV |
1 | 1 |
$86,000 |
| ALTEN TECHNOLOGY USA, INC. |
Level IV |
1 | 1 |
$80,000 |
| Ampersand Biomedicines, Inc. |
Level III |
1 | 1 |
$75,000 |
| Apriori Bio, Inc. |
Level IV |
1 | 1 |
$85,000 |
| Asimov, Inc. |
Level II |
1 | 1 |
$80,855 |
| Asimov, Inc. |
Level IV |
1 | 1 |
$80,855 |
| Beth Israel Deaconess Medical Center, Inc. |
Level I |
1 | 1 |
$44,387 |
| Bonito Biosciences, Inc. |
Level III |
1 | 1 |
$77,501 |
| BostonGene Corporation |
Level III |
1 | 1 |
$72,000 |
| CRISPR Therapeutics, Inc. |
Level IV |
1 | 1 |
$92,000 |
| Diagonal Therapeutics, Inc. |
Level IV |
1 | 1 |
$90,000 |
| Discovery Life Sciences |
Level II |
1 | 1 |
$72,197 |
| EMD MILLIPORE CORPORATION |
Level II |
1 | 1 |
$62,000 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC |
Level III |
1 | 1 |
$75,000 |
| Flagship Labs 107, Inc. |
Level III |
1 | 1 |
$80,000 |
| Flagship Labs 110, Inc. |
Level II |
1 | 1 |
$75,000 |
| Flagship Pioneering, Inc. |
Level IV |
1 | 1 |
$85,000 |
| GEL4MED, INC. |
Level III |
1 | 1 |
$67,621 |
| The General Hospital Corporation |
Level III |
1 | 1 |
$65,000 |
| IM PRO MAKEUP NY LP |
Level III |
1 | 1 |
$75,000 |
| IM PRO MAKEUP NY LP |
Level IV |
1 | 1 |
$87,000 |
| Invaio Sciences, Inc. |
Level II |
1 | 1 |
$85,000 |
| Lila Sciences, Inc. |
Level III |
1 | 1 |
$80,000 |
| Lila Sciences, Inc. |
Level IV |
1 | 1 |
$80,000 |
| LONZA HOUSTON INC |
Level I |
1 | 1 |
$60,445 |
| Massachusetts Eye and Ear Infirmary |
Level II |
1 | 1 |
$62,004 |
| Medicilon USA Corp |
Level II |
1 | 1 |
$58,000 |
| Modalis Therapeutics, Inc |
Level IV |
1 | 1 |
$78,000 |
| New England Biolabs, Inc. |
Level III |
1 | 1 |
$76,883 |
| Novartis Institutes for BioMedical Research, Inc. |
Level II |
1 | 1 |
$57,741 |
| ProFound Therapeutics, Inc. |
Level III |
1 | 1 |
$74,000 |
| ProFound Therapeutics, Inc. |
Level IV |
1 | 1 |
$85,000 |
| QLD Biotherapeutics Inc. |
Level IV |
1 | 1 |
$87,000 |
| Repertoire Immune Medicines, Inc. |
Level III |
1 | 1 |
$80,000 |
| Repertoire Immune Medicines, Inc. |
Level IV |
1 | 1 |
$90,000 |
| Replimune Inc. |
Level III |
1 | 1 |
$106,080 |
| Sai Life Sciences, Inc. |
Level II |
1 | 1 |
$81,652 |
| Sail Biomedicines, Inc. |
Level III |
1 | 1 |
$85,000 |
| Sanofi Vaccines US Inc. |
Level II |
1 | 1 |
$75,000 |
| Serif Biomedicines, Inc. |
Level IV |
1 | 1 |
$87,500 |
| Spear Bio Inc. |
Level II |
1 | 1 |
$80,000 |
| Stellaromics, Inc. |
Level IV |
1 | 1 |
$95,909 |
| Takeda Development Center Americas, Inc. |
Level III |
1 | 1 |
$87,380 |
| TEKWISSEN LLC. |
Level I |
1 | 1 |
$52,000 |
| Tufts University |
Level III |
1 | 1 |
$70,000 |
| VidaVinci, Inc. |
Level IV |
1 | 1 |
$78,000 |
| Whitehead Institute for Biomedical Research |
Level II |
1 | 1 |
$92,061 |
| WHOOP Inc. |
Level I |
1 | 1 |
$65,000 |
| Yoh, A Day & Zimmermann Company |
Level II |
1 | 1 |
$58,240 |
| Yoh, A Day & Zimmermann Company |
Level III |
1 | 1 |
$67,808 |
| Evolved By Nature, Inc. |
Level IV |
1 | 1 |
$112,143 |
| Sarepta Therapeutics, Inc. |
Level IV |
1 | 1 |
$76,000 |
| Arbor Biotechnologies, Inc. |
Level IV |
1 | 1 |
$104,000 |
| Replimune Inc. |
Level II |
1 | 1 |
$81,494 |
| University of Massachusetts Lowell |
not stated |
1 | 1 |
$130,544 |